Estimaciones de analistas de Wall Street para Atea Pharmaceuticals, Inc. (AVIR): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-11 | $-0.51 | ||
| 2026-08-12 | $-0.41 | $-0.56 | +26.1% |
| 2026-05-12 | $-0.57 | $-0.60 | +5.0% |
| 2026-03-05 | $-0.57 | $-0.49 | -16.3% |
| 2025-11-12 | $-0.53 | $-0.46 | -15.2% |
| 2025-08-07 | $-0.44 | $-0.46 | +4.3% |
| 2025-05-12 | $-0.40 | $-0.56 | +28.6% |
| 2025-03-06 | $-0.40 | $-0.35 | -14.3% |
Ratios de valoración
| Precio / Valor contable | 1.84 |
| EV / EBITDA | -2.04 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | 0 | $48.6M | $351.4M | 0 | 0 | 0 | 0 |
| Coste de Ventas | $17000 | $17000 | $38.0M | $167.2M | $62.4M | $70.1M | $83.4M | 0 |
| Beneficio Bruto | -$17000 | -$17000 | $10.6M | $184.2M | -$62.4M | -$70.1M | -$83.4M | 0 |
| I+D | $6.7M | $10.2M | $38.0M | $167.2M | $88.8M | $132.8M | $145.4M | $148.0M |
| Generales y Administrativos | $2.8M | $4.4M | $21.6M | $45.8M | $48.7M | $49.9M | $48.8M | $32.9M |
| Gastos Operativos | $9.5M | $14.6M | $21.6M | $45.8M | $68.3M | $94.1M | $109.6M | $180.9M |
| Beneficio Operativo | -$9.5M | -$14.6M | -$11.0M | $138.4M | -$130.7M | -$164.2M | -$192.9M | -$180.9M |
| EBITDA | -$9.5M | -$14.6M | -$11.0M | $138.6M | -$110.8M | -$119.6M | -$131.8M | -$164.1M |
| Gastos por Intereses | 0 | 0 | 0 | 0 | $11.2M | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$9.1M | -$14.0M | -$10.9M | $138.6M | -$119.5M | -$134.9M | -$167.5M | -$164.5M |
| Impuestos | 0 | 0 | 0 | $17.4M | -$3.6M | $1.0M | $925000 | -$6.2M |
| Beneficio Neto | -$9.1M | -$13.5M | -$10.9M | $121.2M | -$115.9M | -$136.0M | -$168.4M | -$158.3M |
| BPA | $-0.90 | $-0.16 | $-0.13 | $1.46 | $-1.39 | $-1.63 | $-2.00 | $-1.94 |
| BPA Diluido | $-0.90 | $-0.16 | $-0.13 | $1.37 | $-1.39 | $-1.63 | $-2.00 | $-1.94 |
| Acciones en Circulación (Diluidas) | $10.1M | $82.6M | $82.4M | $88.2M | $83.2M | $83.4M | $84.3M | $81.5M |
Precio
| Precio | $5.15 |
| Capitalización | $412M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: ACHV · ALLO · ARCT · ENTA · HUMA · PYXS · TRDA
Explorar sector: Healthcare · Biotechnology
Más secciones de AVIR: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones